Related Experiment Videos
The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction
1ICOS Corporation, Bothell, WA 98021, USA.
Immunology Today
|August 4, 1999
Abstract:
The Cbl protooncoprotein has recently emerged as a component of tyrosine kinase-mediated signal transduction in a variety of cell types. Here, we discuss evidence that supports a role for Cbl as a novel negative regulator of immune receptor signaling, and present models for its mode of function.
Insights
The Cbl protooncoprotein acts as a negative regulator in immune receptor signaling pathways. This research explores its function in tyrosine kinase signal transduction across various cell types.
Area of Science:
- Molecular Biology
- Immunology
- Cell Signaling
Background:
- The Cbl protooncoprotein is recognized as a key player in tyrosine kinase-mediated signal transduction.
- Its precise role in immune cell function requires further elucidation.
Purpose of the Study:
- To investigate the function of the Cbl protooncoprotein in immune receptor signaling.
- To present models detailing the mechanism of Cbl's action.
Main Methods:
- Review of existing evidence on Cbl's role in signal transduction.
- Analysis of Cbl's involvement in immune receptor pathways.
Main Results:
- Evidence suggests Cbl functions as a novel negative regulator of immune receptor signaling.
- Cbl's involvement is observed in diverse cell types utilizing tyrosine kinase pathways.
Conclusions:
- The Cbl protooncoprotein plays a critical role in modulating immune responses.
- Understanding Cbl's regulatory function provides insights into immune signaling networks.